Genistein Sensitizes Bladder Cancer Cells to HCPT Treatment In Vitro and In Vivo via ATM/NF-κB/IKK Pathway-Induced Apoptosis. The gene discussed is NFKB1; the disease is urinary bladder carcinoma.